Danimer Scientific Inc

Danimer Scientific — Q3 2023 Earnings Presentation

12 slides from Danimer Scientific's earnings presentation, Nov 14, 2023

  1. Slide 1: Third Quarter 2023 Earnings Presentation

    Third Quarter 2023 Earnings Presentation November 14, 2023

  2. Slide 2: Disclaimer and Forward-Looking Statements

    This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale w

  3. Slide 3: Fast Facts

    FAST FACTS Founded in 2004 (went public in 2020) 480 patents & pending patent applications 15 partnerships with major brands and distributors 263 Teammates 2018 and 2020 recipient of PLASTICS Innovation in Bioplastics Award Locations in Georgia, Kentucky and New York Manufacturer and developer of PH

  4. Slide 4: Proprietary PHA-Based Resins with Disruptive Performance

    Certified biodegradable for home compost, natural soil and marine environments Highly-engineered to run on standard manufacturing equipment Indistinguishable from petroleum-based plastic to consumers at end-use Proprietary PHA-Based Resins with Disruptive Performance 1 Switch to PHA-based resin requ

  5. Slide 5: Recent Customer & Business Development Highlights

    New program expected to require ~20 million pounds of annual volume of Nodax® cutlery resins; first shipments anticipated mid-year 2024. Bacardi partnership for compostable bottle continues and was extended into other categories to eliminate additional sources of plastic waste. Delta Cafes now launc

  6. Slide 6: Kentucky Manufacturing – Process & Capability

    Kentucky Manufacturing – Process & Capability ¹ Intended to illustrate maximum potential at full utilization of design capacity; assumes pricing of $3 per lb. Facility Targets: ~32.5 M LBS of Neat PHA ~65 M LBS Formulated PHA-Based Resin ~$190 M Revenue¹ 6 Continuous innovation effort reveals potent

  7. Slide 7: Q3 2023 Financial Summary

    Q3 2023 Financial Summary 3Q23 sales increase versus last year driven entirely by strength in sales of PHA-based resins (up $3.1 million or 58% versus prior year) partially offset by a $1.8 million reduction in sales of PLA-based resins as well as lower R&D and other service revenue. Increased Adjus

  8. Slide 8: Guidance Summary

    Revised Adj. EBITDA guidance range of $(40) to $(37) million. Guidance revision reflects later than anticipated timing of revenues associated with customer product launches. Remain confident that volume associated with new programs is intact. Numerous and diversified engagement opportunities for lon

  9. Slide 9: tess, ~ e

    AN y . tess, ~ e Zé danimer \ oe soienutic. ‘y __ ABiotechnology Company

  10. Slide 10: EBITDA Reconciliation

    danimer scientific EBITDA Reconciliation A Biotechnology Company $ Thousands Net loss ($40,159) ($94,876) Stock-based compensation 14,324 14,305 Interest, net 8,584 553 Depreciation and amortization 7,253 4,585 Income taxes 468 (236) Remeasurement of private warrants (132) (1,607) Strategic reorgani

  11. Slide 11: Adjusted Gross Profit Reconciliation

    Adjusted Gross Profit Reconciliation 11

  12. Slide 12: Thank You

    a danimer ~ scientific THANK YOU

Danimer Scientific — Q3 2023 Earnings Presentation on 6ix